176 related articles for article (PubMed ID: 22405917)
1. Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer.
Hessman CJ; Bubbers EJ; Billingsley KG; Herzig DO; Wong MH
Am J Surg; 2012 May; 203(5):649-653. PubMed ID: 22405917
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.
Gong Y; Wang J; Huo L; Wei W; Ueno NT; Woodward WA
Clin Breast Cancer; 2014 Jun; 14(3):e81-8. PubMed ID: 24461456
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer.
Martín M; Hinojar A; Cerezo L; García J; Lopez M; Prada J; Marín A; Gamallo C
Clin Transl Oncol; 2016 Aug; 18(8):825-30. PubMed ID: 26572760
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1: a specific cancer stem cell marker for human colorectal carcinoma.
Zhou F; Mu YD; Liang J; Liu ZX; Zhou D; Ning WL; Li YZ; Ding D; Zhang JF
Mol Med Rep; 2015 May; 11(5):3894-9. PubMed ID: 25585687
[TBL] [Abstract][Full Text] [Related]
6. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
[TBL] [Abstract][Full Text] [Related]
7. Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer.
Goossens-Beumer IJ; Zeestraten EC; Benard A; Christen T; Reimers MS; Keijzer R; Sier CF; Liefers GJ; Morreau H; Putter H; Vahrmeijer AL; van de Velde CJ; Kuppen PJ
Br J Cancer; 2014 Jun; 110(12):2935-44. PubMed ID: 24786601
[TBL] [Abstract][Full Text] [Related]
8. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of association of cancer stem cell marker aldehyde dehydrogenase 1 with clinicopathological profile in lung carcinoma patients.
Tiwari N; Srivastava AN; Tandon N; Lal N; Yadav S; Kant S; Jain M
Indian J Pathol Microbiol; 2018; 61(4):489-494. PubMed ID: 30303135
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Zhu B; Zhou L; Yu L; Wu S; Song W; Gong X; Wang D
BMC Surg; 2017 Apr; 17(1):47. PubMed ID: 28431527
[TBL] [Abstract][Full Text] [Related]
12. ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Wei D; Peng JJ; Gao H; Zhang T; Tan Y; Hu YH
Heart Lung Circ; 2015 Aug; 24(8):780-8. PubMed ID: 25921687
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Xu N; Shao MM; Zhang HT; Jin MS; Dong Y; Ou RJ; Wang HM; Shi AP
Cancer Epidemiol; 2015 Jun; 39(3):375-81. PubMed ID: 25843691
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma.
Luo WR; Yao KT
Virchows Arch; 2014 Jan; 464(1):35-43. PubMed ID: 24248285
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.
Abourbih S; Sircar K; Tanguay S; Kassouf W; Aprikian A; Mansure J; Brimo F
World J Surg Oncol; 2013 Nov; 11():298. PubMed ID: 24266898
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma.
Wu A; Luo W; Zhang Q; Yang Z; Zhang G; Li S; Yao K
Cancer Lett; 2013 Apr; 330(2):181-9. PubMed ID: 23220285
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
[TBL] [Abstract][Full Text] [Related]
19. ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
Koh YW; Han JH; Haam S; Jung J
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1427-1436. PubMed ID: 30923946
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
Charafe-Jauffret E; Ginestier C; Iovino F; Tarpin C; Diebel M; Esterni B; Houvenaeghel G; Extra JM; Bertucci F; Jacquemier J; Xerri L; Dontu G; Stassi G; Xiao Y; Barsky SH; Birnbaum D; Viens P; Wicha MS
Clin Cancer Res; 2010 Jan; 16(1):45-55. PubMed ID: 20028757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
